Novavax | NVAX - 股票

金融业

USD 12.82

USD 955.58M

现金及等价物

USD 191.46M

USD 22.1M

USD 771.1M

USD 330.57M

USD 233.31M

USD 20.94M

USD 19.36M

1.54K

EPS每股收益

USD 0.13

股本和储备

USD -190.71M

USD 125.04M

债务利息支出

USD 5.82M

USD 303K

USD 246.3M

USD 1.79B

USD 17.53M

USD 126.2M

USD 20.94M

普通股股本

USD 162.58M

2.01

USD 17.9M

USD 147.14M

销售和管理费用

USD 25.53M

USD 10.01M

贸易债权人

USD 22.94M

应收帐款人

USD 106.45M

	股票	更改		日
Adma Biologics	USD 239.31M		17.22M	2026-06
AstraZeneca	USD 6.93B		362M	2026-06
BioCryst Pharmaceuticals	USD 6.06M		71K	2026-06
Geron	USD 123.6M		9.68M	2026-06
GlaxoSmithKline	GBP 6.16B		233M	2026-03
MannKind	USD 44.42M		4.75M	2026-06
Merck	USD 6.21B		272M	2026-06
Moderna	USD 280M		134M	2026-06
Novartis	USD 6.29B		135M	2026-03
Novavax	USD 10.01M		1.45M	2026-06
Pfizer	USD 9.94B		722M	2026-06
Sanofi	EUR 24.12B		620M	2026-06
Sarepta Therapeutics	USD 904.27M		96.84M	2026-06
TG Therapeutics	USD 147.97M		18.94M	2026-06